Clinical Trials Browser

Phase 2 × Neuroectodermal Tumors, Primitive, Peripheral × trioctyl phosphine oxide × Clear all

NCT00516295 2014-09-02

Vincristine Sulfate, Topotecan Hydrochloride, and Cyclophosphamide With or Without Bevacizumab in Treating Young Patients With Refractory or First Recurrent Extracranial Ewing Sarcoma

Phase 2 Completed

7 enrolled 6 charts

Neuroectodermal Tumors, Primitive, Peripheral